{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:26Z","timestamp":1790096906102,"version":"4.0.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["21\/PATH-S\/9634"],"award-info":[{"award-number":["21\/PATH-S\/9634"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drudis.2026.104785","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:33:56Z","timestamp":1787585636000},"page":"104785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence (AI)-enabled platforms for cancer vaccine engineering"],"prefix":"10.1016","volume":"31","author":[{"given":"Ajay K.","family":"Mali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabya Sachi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-527X","authenticated-orcid":false,"given":"Nanasaheb D.","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104785_b0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/vaccines13121231","article-title":"Personalized cancer vaccines: current advances and emerging horizons","volume":"13","author":"Lu","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.drudis.2026.104785_b0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/cancers18010144","article-title":"Advances in neoantigen-based cancer vaccines","volume":"18","author":"Wu","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.drudis.2026.104785_b0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10238-024-01436-7","article-title":"Personalized neoantigen cancer vaccines: current progression, challenges and a bright future","volume":"24","author":"Wu","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.drudis.2026.104785_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","article-title":"The promise of mRNA vaccines: a biotech and industrial perspective","volume":"5","author":"Jackson","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.drudis.2026.104785_b0025","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104785_b0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/biom14040503","article-title":"Recent findings on therapeutic cancer vaccines: an updated review","volume":"14","author":"Sheikhlary","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104785_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-024-01102-w","article-title":"Advances in nucleic acid-based cancer vaccines","volume":"32","author":"Liao","year":"2025","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.drudis.2026.104785_b0335","article-title":"DNA vaccines as promising immuno-therapeutics against cancer: a new insight","volume":"15","author":"Shariati","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104785_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001111","article-title":"Antigen processing and presentation in cancer immunotherapy","volume":"8","author":"Lee","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.drudis.2026.104785_b0115","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1158\/0008-5472.CAN-24-2553","article-title":"Leveraging artificial intelligence for neoantigen prediction","volume":"85","author":"Zeng","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104785_b0225","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s42256-025-01002-0","article-title":"A unified deep framework for peptide\u2013major histocompatibility complex\u2013T cell receptor binding prediction","volume":"7","author":"Zhao","year":"2025","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/biochem5020005","article-title":"Advances in personalized cancer vaccine development: AI applications from neoantigen discovery to mRNA formulation","volume":"5","author":"Kong","year":"2025","journal-title":"BioChem"},{"key":"10.1016\/j.drudis.2026.104785_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077341","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2026.104785_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1357217","article-title":"Personalized cancer vaccine design using AI-powered technologies","volume":"15","author":"Kumar","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104785_b0055","article-title":"Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy","volume":"14","author":"Imani","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2026.104785_b0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/ph17040419","article-title":"AutoPepVax, a novel machine-learning-based program for vaccine design: application to a pan-cancer vaccine targeting EGFR missense mutations","volume":"17","author":"Bautista","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2026.104785_b0065","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/1078-0432.CCR-23-3940","article-title":"Phase I trial of viral vector-based personalized vaccination elicits robust neoantigen-specific antitumor T-cell responses","volume":"30","author":"D\u2019Alise","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104785_b0070","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41587-024-02420-y","article-title":"A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy","volume":"43","author":"Huber","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104785_b0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104785_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/prca.70018","article-title":"Artificial intelligence and the evolving landscape of immunopeptidomics","volume":"19","author":"Vo","year":"2025","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.drudis.2026.104785_b0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-biodatasci-021920-100259","article-title":"Immunoinformatics: predicting peptide\u2013MHC binding","volume":"3","author":"Nielsen","year":"2020","journal-title":"Annu Rev Biomed Data Sci"},{"key":"10.1016\/j.drudis.2026.104785_b0095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41587-019-0289-6","article-title":"Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes","volume":"37","author":"Racle","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104785_b0100","article-title":"Supervised contrastive learning enhances MHC-II peptide binding affinity prediction","author":"Shen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104785_b0105","article-title":"Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation","volume":"22","author":"Pyke","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2026.104785_b0110","doi-asserted-by":"crossref","first-page":"10752","DOI":"10.1038\/s41467-024-54887-7","article-title":"Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model","volume":"15","author":"Thrift","year":"2024","journal-title":"Hlapollo Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0120","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae547","article-title":"NeoaPred: a deep-learning framework for predicting immunogenic neoantigen based on surface and structural features of peptide\u2013human leukocyte antigen complexes","volume":"40","author":"Jiang","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104785_b0125","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104785_b0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing","volume":"11","author":"O\u2019Donnell","year":"2020","journal-title":"Cell Syst"},{"key":"10.1016\/j.drudis.2026.104785_b0135","article-title":"TCRex: detection of enriched T cell epitope specificity in full T cell receptor sequence repertoires","author":"Gielis","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104785_b0140","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/s41467-021-21879-w","article-title":"DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires","volume":"12","author":"Sidhom","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0150","doi-asserted-by":"crossref","DOI":"10.2147\/JMDH.S572089","article-title":"Artificial intelligence-enabled multi-omics for predicting immune checkpoint inhibitor response and resistance","volume":"19","author":"Wang","year":"2026","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.drudis.2026.104785_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116704","article-title":"Multi-omics-guided characterization of neoantigens improves patient stratification and potentiates combinatorial immunotherapy in glioma","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2026.104785_b0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2020.05.001","article-title":"Emerging technologies for systems vaccinology\u2014multi-omics integration and single-cell (epi)genomic profiling","volume":"65","author":"Wimmers","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.drudis.2026.104785_b0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104785_b0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41583-020-0313-3","article-title":"Reproducibility of animal research in light of biological variation","volume":"21","author":"Voelkl","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.drudis.2026.104785_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41746-020-00376-2","article-title":"Deep learning-enabled medical computer vision","volume":"4","author":"Esteva","year":"2021","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.drudis.2026.104785_b0180","first-page":"11","article-title":"AI-driven advances in precision oncology: toward optimizing cancer diagnostics and personalized treatment","volume":"7","author":"Bulic","year":"2026","journal-title":"AI (Basel)"},{"key":"10.1016\/j.drudis.2026.104785_b0185","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-023-40890-x","article-title":"Biology-guided deep learning predicts prognosis and cancer immunotherapy response","volume":"14","author":"Jiang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/ani15030389","article-title":"Advancing veterinary oncology: next-generation diagnostics for early cancer detection and clinical implementation","volume":"15","author":"Alshammari","year":"2025","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.drudis.2026.104785_b0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cpt.1951","article-title":"Artificial intelligence and mechanistic modeling for clinical decision making in oncology","volume":"108","author":"Benzekry","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104785_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41746-024-01043-6","article-title":"Informing immunotherapy with multi-omics driven machine learning","volume":"7","author":"Li","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.drudis.2026.104785_b0205","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/pharmaceutics15020654","article-title":"In silico studies to support vaccine development","volume":"15","author":"Saldanha","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2026.104785_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2025.1620572","article-title":"Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics\u2014yesterday, today, and tomorrow","volume":"8","author":"Elfatimi","year":"2025","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0210","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.apsb.2023.11.003","article-title":"A novel deep generative model for mRNA vaccine development: designing 5\u2032 UTRs with N1-methyl-pseudouridine modification","volume":"14","author":"Tang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2026.104785_b0215","article-title":"Joint design of 5\u2032 untranslated region and coding sequence of mRNA","author":"Liu","year":"2024","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104785_b0220","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0230","article-title":"THLANet (2025)","volume":"21","author":"Long","year":"2025","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.drudis.2026.104785_b0235","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1038\/s41598-021-81749-9","article-title":"An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104785_b0240","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s42256-021-00383-2","article-title":"Deep learning-based prediction of the T cell receptor\u2013antigen binding specificity","volume":"3","author":"Lu","year":"2021","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0245","article-title":"TransMut: a program to predict HLA-I peptide binding and optimize mutated peptides for vaccine design by the Transformer-derived self-attention model","author":"Chu","year":"2021","journal-title":"Res Sq"},{"key":"10.1016\/j.drudis.2026.104785_b0250","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae625","article-title":"Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy","volume":"26","author":"Xu","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.drudis.2026.104785_b0255","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s42256-024-00971-y","article-title":"Deep learning enhances the prediction of HLA class I-presented CD8+ T cell epitopes in foreign pathogens","volume":"7","author":"Wohlwend","year":"2025","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s42256-024-00823-9","article-title":"A 5\u2032 UTR language model for decoding untranslated regions of mRNA and function predictions","volume":"6","author":"Chu","year":"2023","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0265","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s41592-024-02487-0","article-title":"Accurate RNA 3D structure prediction using a language model-based deep learning approach","volume":"21","author":"Shen","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104785_b0270","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae330","article-title":"CodonBERT: a BERT-based architecture tailored for codon optimization using the cross-attention mechanism","volume":"40","author":"Ren","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104785_b0275","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s42256-025-01073-z","article-title":"Self-iterative multiple-instance learning enables the prediction of CD4+ T cell immunogenic epitopes","volume":"7","author":"Shen","year":"2025","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0280","article-title":"ImmunoStruct: a multimodal neural network framework for immunogenicity prediction from peptide-MHC sequence, structure, and biochemical properties","author":"Krishnaswamy","year":"2025","journal-title":"Res Sq"},{"key":"10.1016\/j.drudis.2026.104785_b0285","series-title":"13th International Conference on Learning Representations, ICLR 2025","first-page":"43379","article-title":"Immunogenicity prediction with dual attention enables vaccine target selection","author":"Li","year":"2024"},{"key":"10.1016\/j.drudis.2026.104785_b0290","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae302","article-title":"HLAIImaster: a deep learning method with adaptive domain knowledge predicts HLA II neoepitope immunogenic responses","volume":"25","author":"Yang","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.drudis.2026.104785_b0295","doi-asserted-by":"crossref","first-page":"W134","DOI":"10.1093\/nar\/gkad275","article-title":"DeepNeo: a webserver for predicting immunogenic neoantigens","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104785_b0305","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/bioinformatics\/btab422","article-title":"BERTMHC: improved MHC\u2013peptide class II interaction prediction with transformer and multiple instance learning","volume":"37","author":"Cheng","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104785_b0310","article-title":"RPEMHC: improved prediction of MHC\u2013peptide binding affinity by a deep learning approach based on residue\u2013residue pair encoding","volume":"40","author":"Wang","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104785_b0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104785_b0320","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1473-3099(25)00497-9","article-title":"Artificial intelligence in the development of vaccines for infectious diseases","volume":"26","author":"Black","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2026.104785_b0325","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s42256-023-00694-6","article-title":"Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity","volume":"5","author":"Albert","year":"2023","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.drudis.2026.104785_b0340","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv6445","article-title":"Immunopeptidomics-guided discovery and characterization of neoantigens for personalized cancer immunotherapy","volume":"11","author":"Cai","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104785_b0345","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41467-024-45766-2","article-title":"Design of target specific peptide inhibitors using generative deep learning and molecular dynamics simulations","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0350","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/0008-5472.CAN-24-0565","article-title":"Personalized cancer vaccines directed against tumor mutations: building evidence from mice to humans","volume":"84","author":"Fritsch","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104785_b0355","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1038\/s41467-025-62647-4","article-title":"Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics","volume":"16","author":"Shapiro","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/narcan\/zcae002","article-title":"A large-scale study of peptide features defining immunogenicity of cancer neo-epitopes","volume":"6","author":"Wan","year":"2024","journal-title":"NAR Cancer"},{"key":"10.1016\/j.drudis.2026.104785_b0040","first-page":"1","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104785_b0370","article-title":"Recent advances in lipid nanoparticles for cancer vaccine delivery: challenges and future perspectives","volume":"11","author":"Hasan","year":"2026","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.drudis.2026.104785_b0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12645-025-00326-1","article-title":"Current state-of-the-art in multi-scale modeling in nano-cancer drug delivery: role of AI and machine learning","volume":"16","author":"Debnath","year":"2025","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.drudis.2026.104785_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104785_b0375","doi-asserted-by":"crossref","DOI":"10.1093\/mam\/ozae044.196","article-title":"AI-enhanced nanoparticle analysis: integrating single-shot object detection and vision transformer for rapid and accurate characterization","volume":"30","author":"Genc","year":"2024","journal-title":"Microsc Microanal"},{"key":"10.1016\/j.drudis.2026.104785_b0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/diseases13010024","article-title":"Integrating AI into cancer immunotherapy\u2014a narrative review of current applications and future directions","volume":"13","author":"Olawade","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.drudis.2026.104785_b0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eng.2024.12.014","article-title":"Artificial intelligence in cancer immunotherapy: navigating challenges and unlocking opportunities","volume":"44","author":"Xiang","year":"2025","journal-title":"Engineering"},{"key":"10.1016\/j.drudis.2026.104785_b0395","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2025.03.018","article-title":"New horizons at the interface of artificial intelligence and translational cancer research","volume":"43","author":"Yates","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2026.104785_b0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.11.008","article-title":"Artificial intelligence for prediction of response to cancer immunotherapy","volume":"87","author":"Yang","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.drudis.2026.104785_b0405","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i10.111339","article-title":"Revolutionizing gastrointestinal cancer research with artificial intelligence: from precision patient stratification to real-world evidence","volume":"17","author":"Wang","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.drudis.2026.104785_b0410","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12967-025-06308-6","article-title":"Artificial intelligence-driven translational medicine: a machine learning framework for predicting disease outcomes and optimizing patient-centric care","volume":"23","author":"Abualigah","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2026.104785_b0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s44272-025-00052-0","article-title":"Advancing cancer care through artificial intelligence: from innovative models to clinical decision-making and regulatory integration","volume":"4","author":"Subhan","year":"2025","journal-title":"Clin Cancer Bull"},{"key":"10.1016\/j.drudis.2026.104785_b0415","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/1538-7445.AM2025-3649","article-title":"Abstract 3649: artificial intelligence accelerates shared neoantigen peptide cancer vaccine development","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104785_b0425","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae205","article-title":"NeoAgDT: optimization of personal neoantigen vaccine composition by digital twin simulation of a cancer cell population","volume":"40","author":"M\u00f6sch","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104785_b0430","article-title":"Digital twins in oncology: where we are and where we hope to go","volume":"4","author":"McCoy","year":"2025","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.drudis.2026.104785_b0435","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.3390\/jcm14103574","article-title":"Exploring the potential of digital twins in cancer treatment: a narrative review of reviews","volume":"14","author":"Giansanti","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.drudis.2026.104785_b0440","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/jpm15110503","article-title":"Digital twins in personalized medicine: bridging innovation and clinical reality","volume":"15","author":"Silva","year":"2025","journal-title":"J Pers Med"},{"key":"10.1016\/j.drudis.2026.104785_b0445","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu3791","article-title":"Vaccinology in the artificial intelligence era","volume":"17","author":"Gasperini","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2026.104785_b0450","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s15010-024-02347-1","article-title":"Innovative approaches for vaccine trials as a key component of pandemic preparedness \u2013 a white paper","volume":"52","author":"Bethe","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.drudis.2026.104785_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567116","article-title":"Artificial intelligence in vaccine research and development: an umbrella review","volume":"16","author":"El Arab","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104785_b0460","first-page":"8","article-title":"Advancing single-shot vaccine design through AI and computational models","volume":"7","author":"Gude","year":"2025","journal-title":"Transl Regul Sci"},{"key":"10.1016\/j.drudis.2026.104785_b0465","article-title":"Deep learning and explainable AI: new pathways to genetic insights","author":"Wang","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104785_b0470","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1591696","article-title":"Advancing precision oncology with AI-powered genomic analysis","volume":"16","author":"Srivastava","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104785_b0475","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/singaporemedj.SMJ-2023-279","article-title":"Ethics of artificial intelligence in medicine","volume":"65","author":"Savulescu","year":"2024","journal-title":"Singapore Med J"},{"key":"10.1016\/j.drudis.2026.104785_b0480","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.3390\/app14198884","article-title":"Recent applications of explainable AI (XAI): a systematic literature review","volume":"14","author":"Saarela","year":"2024","journal-title":"Appl Sci"},{"key":"10.1016\/j.drudis.2026.104785_b0485","doi-asserted-by":"crossref","first-page":"170","DOI":"10.30574\/wjaets.2025.14.3.0106","article-title":"(XAI) for trustworthy and transparent decision-making: a theoretical framework for AI interpretability","volume":"14","author":"Arunraju","year":"2025","journal-title":"World J Adv Eng Technol Sci"},{"key":"10.1016\/j.drudis.2026.104785_b0490","series-title":"Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations","author":"US Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.drudis.2026.104785_b0495","series-title":"Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions","author":"US Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.drudis.2026.104785_b0500","series-title":"Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products","author":"US Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.drudis.2026.104785_b0505","series-title":"Reflection Paper on the Use of Artificial Intelligence (AI) in the Medicinal Product Lifecycle","author":"European Medicines Agency","year":"2024"},{"key":"10.1016\/j.drudis.2026.104785_b0510","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2570962","article-title":"Legal questions of AI-generated immunological products for infectious diseases","volume":"21","author":"Zumarraga","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.drudis.2026.104785_b0515","doi-asserted-by":"crossref","DOI":"10.2196\/76634","article-title":"Ethical implications of artificial intelligence in vaccine equity: protocol for exploring vaccine distribution planning and scheduling in pandemics in low- and middle-income countries","volume":"14","author":"Akuma","year":"2025","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.drudis.2026.104785_b0520","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1017\/jme.2025.10141","article-title":"Competition law and ethics of innovation as catalysts for fairness: reimagining the EU\u2019s COVID-19 vaccine strategy","volume":"53","author":"Hosseini","year":"2025","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.drudis.2026.104785_b0525","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104785_b0530","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104785_b0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1013163","article-title":"Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions","volume":"21","author":"Voutouri","year":"2025","journal-title":"PLoS Comput Biol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462600190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462600190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:17:51Z","timestamp":1790093871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462600190X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S135964462600190X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104785","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence (AI)-enabled platforms for cancer vaccine engineering","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104785"}}